Form D · Other Health Care
BioPorto A/S
Hellerup, G7 · CIK 0001805052
Offering snapshot reported Jul 31, 2023 · SEC filing
- Reported sold
- $110K Offering amount: $110K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 23, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2023 | Initial | $110,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-488330
Source: Form D, filed Jul 31, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jan Leth Christensen | Director |
| Peter Morch Eriksen | Director |
| Neil Goldman | Executive |
| Don Hardison, Jr. | Director |
| John Mc Donough | Director |
| Anthony Pare | Executive |
| Ninfa Saunders | Director |
| Michael Singer | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
Tuborg Havnevej 15, St
Hellerup, G7, DK-2900
Hellerup, G7, DK-2900